108 related articles for article (PubMed ID: 4291902)
1. The effects of mepyrapone (SU 4885) and some hypercholesterolaemic drugs on hepatic sterol and fatty acid oxidation.
Dean PD; Whitehouse MW
Biochem Pharmacol; 1967 Mar; 16(3):441-6. PubMed ID: 4291902
[No Abstract] [Full Text] [Related]
2. Effects of MER-29 on sterol concentration in rat tissues and on cholesterol biosynthesis in vivo and in vitro from mevalonic acid-2-C14.
GOULD RG
Prog Cardiovasc Dis; 1960 May; 2():492-503. PubMed ID: 13828582
[No Abstract] [Full Text] [Related]
3. Phosphorylation coupled to acyl-coenzyme A dehydrogenase-linked oxidation of fatty acids by liver and heart mitochondria.
Bremer J; Davis EJ
Biochim Biophys Acta; 1972 Sep; 275(3):298-301. PubMed ID: 5070055
[No Abstract] [Full Text] [Related]
4. Effects of inhibitors of sterol synthesis on growth of sordaria and phytophthora.
Elliott CG
J Gen Microbiol; 1969 Jun; 56(3):331-43. PubMed ID: 5793122
[No Abstract] [Full Text] [Related]
5. Conversion of beta sitosterol to cholesterol blocked in an insect by hypocholesterolemic agents.
Svoboda JA; Robbins WE
Science; 1967 Jun; 156(3782):1637-8. PubMed ID: 6025125
[TBL] [Abstract][Full Text] [Related]
6. Pathways of enzymic synthesis and conversion to cholesterol of delta-5,7,24-cholestatrien-3 beta-ol and other naturally occurring sterols.
Dempsey ME
J Biol Chem; 1965 Nov; 240(11):4176-88. PubMed ID: 4378934
[No Abstract] [Full Text] [Related]
7. Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis III. Zuclomiphene in combination with AY9944 and triparanol.
Ramsey RB
Biochem Pharmacol; 1978; 27(12):1637-40. PubMed ID: 81057
[No Abstract] [Full Text] [Related]
8. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
Illing HP; Kunke S; Netter KJ
Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422
[No Abstract] [Full Text] [Related]
9. Flavoproteins of mitochondrial fatty acid oxidation.
Garland PB; Chance B; Ernster L; Lee CP; Wong D
Proc Natl Acad Sci U S A; 1967 Oct; 58(4):1696-702. PubMed ID: 4295832
[No Abstract] [Full Text] [Related]
10. Enhancement and inhibition of drug metabolism.
Anders MW
Annu Rev Pharmacol; 1971; 11():37-56. PubMed ID: 5005155
[No Abstract] [Full Text] [Related]
11. Effect of hypocholesteremic compounds on bacterial multiplication.
Aaronson S; Fulco L
J Gen Microbiol; 1968 Feb; 50(2):271-6. PubMed ID: 5640227
[No Abstract] [Full Text] [Related]
12. Study of the cellular action of drugs with protozoa. II. Comparative study of the inhibitions induced by hypocholesteremic agents on Ochromonas danica multiplication; annulment by oleic acid.
Aaronson S; Bensky B
J Protozool; 1965 May; 12(2):236-40. PubMed ID: 5859660
[No Abstract] [Full Text] [Related]
13. Inhibition of intestinal cholesterogenesis in vitro.
Cayen MN; Dvornik D
Proc Soc Exp Biol Med; 1968 Jan; 127(1):117-20. PubMed ID: 5644629
[No Abstract] [Full Text] [Related]
14. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver.
Yamada J; Ogawa S; Horie S; Watanabe T; Suga T
Biochim Biophys Acta; 1987 Sep; 921(2):292-301. PubMed ID: 3651489
[TBL] [Abstract][Full Text] [Related]
15. Effect of methylglyoxal bis(guanylhydrazone) on hepatic, heart and skeletal muscle mitochondrial carnitine palmitoyltransferase and beta-oxidation of fatty acids.
Brady LJ; Brady PS; Gandour RD
Biochem Pharmacol; 1987 Feb; 36(4):447-52. PubMed ID: 3827937
[TBL] [Abstract][Full Text] [Related]
16. THE HYPOCHOLESTEROLEMIC ACTION OF 20,25-DIAZACHOLESTEROL.
RANNEY RE; COOK DL
Arch Int Pharmacodyn Ther; 1965 Mar; 154():51-62. PubMed ID: 14346416
[No Abstract] [Full Text] [Related]
17. Inhibition of Ochromonas respiration by hypocholesteremic compounds and its annulment by unsaturated fatty acids.
Aaronson S; Roze U; Keane M; Zahalsky AC
J Protozool; 1969 Feb; 16(1):184-6. PubMed ID: 5806194
[No Abstract] [Full Text] [Related]
18. [Study of the effect of an inhibitor of carnitine-dependent metabolism of mildronate on the oxidation of fatty acids in the liver mitochondria of intact rats].
Kagan TI; Simkhovich BZ; Kalvinysh IIa; Lukevits EIa
Vopr Med Khim; 1991; 37(2):44-6. PubMed ID: 1897193
[TBL] [Abstract][Full Text] [Related]
19. Experimental myotonia and hypocholesterolemic agents.
Peter JB; Dromgoole SH; Campion DS; Stempel KE; Bowman RL; Andiman RM; Nagatomo T
Exp Neurol; 1975 Oct; 49(1 Pt 1):115-22. PubMed ID: 52555
[No Abstract] [Full Text] [Related]
20. Selective biliary secretion of basal and glucagon-inhibited neutral sterol after triparanol administration.
Meyers WC; Hanks JB; Jakoi L; Quarfordt S; Jones RS
Surgery; 1980 Jul; 88(1):156-61. PubMed ID: 7385018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
